Increased urinary excretion of pyridinium cross-links as markers of bone resorption in bone metastases of lung cancer
โ Scribed by Katsuyuki Tomita; Hideki Kawamura; Ryosuke Nemoto; Tomohiro Ohta; Yoshio Tanabe; Katsuhiko Fukuda; Toshikazu Ikeda; Kouji Fukutani; Takao Sasaki
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 767 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0914-8779
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Objectives: To examine the diagnostic validity of bone alkaline phosphatase (BAP) in serum (a marker of bone formation) and of urinary excretion of pyridinium cross-links (PYR) (a marker of bone resorption) for detection of bone metastases. Design and Methods: Two heterogeneous immunoassays were em
article. P. Roussou contributed to overall study management. E. Matsakas and A. Karavidas
BACKGROUND. We investigated whether a new marker of bone turnover, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), could be useful in the assessment of bone metastasis and in monitoring of the response to treatment in patients with prostate cancer with bone metastasi